A Dendron-Based Fluorescence Turn-On Probe for Tumor Detection

Changren Liu1, Ling'e Zhang1, Sensen Zhou1

  • 1Department of Polymer Science & Engineering, College of Chemistry & Chemical Engineering, Nanjing University, Nanjing, 210023, P.R. China.

Insights

This study introduces novel dendron-based probes that enhance tumor imaging sensitivity. These probes utilize a fluorescence turn-on mechanism activated in tumor environments, improving cancer detection.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Organic Chemistry

Background:

  • Optical probes are crucial for sensitive tumor imaging.
  • Current probes often lack sufficient sensitivity and contrast.
  • Amplifying emission signals in tumors is key to improved detection.

Purpose of the Study:

  • To develop and characterize novel dendron-based fluorescence turn-on probes.
  • To investigate the Förster resonance energy transfer (FRET) mechanism for probe activation.
  • To evaluate the probe's efficacy in tumor imaging in vitro and in vivo.

Main Methods:

  • Synthesis of fourth-generation dendrons with oligo(ethylene glycol) scaffolds via solid-phase synthesis.
  • Conjugation of a Cy5.5 fluorophore and eight Black Hole Quencher 3 (BHQ-3) molecules to the dendron structure.
  • Utilizing a reductively cleavable disulfide linkage for controlled probe activation.
  • In vitro and in vivo experiments to assess probe performance in tumor environments.

Main Results:

  • Dendron-based probes exhibit precise, defect-free chemical structures.
  • Fluorescence is rapidly activated in the reductive environments of tumor cells and tissues.
  • The probes show amplified tumor signals and reduced normal tissue signals.
  • Demonstrated advantages over existing nanoscale probes, including well-defined structures and controllable conjugation.

Conclusions:

  • Dendron-based fluorescence turn-on probes offer a promising new strategy for enhanced tumor detection.
  • The FRET-mediated mechanism and specific design enable sensitive and selective tumor imaging.
  • The probes possess desirable chemical stability and reproducible pharmacokinetic profiles for clinical translation.